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Abstract
Background: In areas where malaria is endemic, pregnancy is associated with increased
susceptibility to malaria. It is generally agreed that this risk ends with delivery and decreases with
the number of pregnancies. Our study aimed to demonstrate relationships between malarial
parasitaemia and age, gravidity and anaemia in pregnant women in Libreville, the capital city of
Gabon.
Methods: Peripheral blood was collected from 311 primigravidae and women in their second
pregnancy. Thick blood smears were checked, as were the results of haemoglobin electrophoresis.
We also looked for the presence of anaemia, fever, and checked whether the volunteers had had
chemoprophylaxis. The study was performed in Gabon where malaria transmission is intense and
perennial.
Results: A total of 177 women (57%) had microscopic parasitaemia; 139 (64%)of them were
primigravidae, 38 (40%) in their second pregnancy and 180 (64%) were teenagers. The parasites
densities were also higher in primigravidae and teenagers. The prevalence of anaemia was 71% and
was associated with microscopic Plasmodium falciparum parasitaemia: women with moderate or
severe anaemia had higher parasite prevalences and densities. However, the sickle cell trait, fever
and the use of chemoprophylaxis did not have a significant association with the presence of P.
falciparum.
Conclusions: These results suggest that the prevalence of malaria and the prevalence of anaemia,
whether associated with malaria or not, are higher in pregnant women in Gabon. Primigravidae and
young pregnant women are the most susceptible to infection. It is, therefore, urgent to design an
effective regimen of malaria prophylaxis for this high risk population.
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In areas where malaria is highly endemic, a protective
semi-immunity against Plasmodium falciparum is acquired
during the first 10–15 years of life, and the majority of
malaria-related morbidity and mortality happens in
young children [1]. However, in contrast with low malaria
prevalence in adults, pregnant women in endemic areas
are highly susceptible to malaria, and both the frequency
and the severity of disease are higher in pregnant than
non-pregnant women [2]. In pregnancy, there is a tran-
sient depression of cell-mediated immunity that allows
foetal allograft retention but also interferes with resistance
to various infectious diseases [3]. Cellular immune
responses to P. falciparum antigens are depressed in preg-
nant women in comparison with non-pregnant control
women [4,5]. Anti-adhesion antibodies against chondroi-
tin sulphate A-binding parasites are associated with pro-
tection from maternal malaria, but these antibodies
develop only over successives pregnancies, accounting for
the susceptibility of primigravidae to infection [6].
Indeed, women in first and second pregnancies are the
most affected, with both gravidity and premunition influ-
encing susceptibility to malaria infection [7–10]. Numer-
ous epidemiological studies have reported a broad range
of conditions during pregnancy which are a result of
malaria [11–15]. As with peripheral parasitaemia, placen-
tal infection is also most frequent and heaviest in primi-
gravidae [16]. Furthermore, malaria reduces birth-weight
most in this group [16]. Although this data has been
reported in many African countries, hardly anything is
known about malaria in pregnant women from Gabon, a
central African country where P. falciparum malaria is
endemic. Thus, we conducted a community-based cross-
sectional study to describe the prevalence of malaria par-
asitaemia and anaemia in pregnant women living in
Libreville. As the prevalence of infection is lower in indi-
viduals with sickle cell trait compared with their normal
haemoglobin counterparts [17], we also studied the fre-
quency of the sickle cell trait.
Patients and methods
Study site and population
The study area is in Libreville, Gabon, where the climate is
equatorial. Two rainy seasons occur in Gabon, from Feb-
ruary to May and September to December, and two dry
seasons. The annual temperature ranges from 24°C to
31°C (average 25.9°C), and the average humidity is
greater than 80%. In this area, malaria is hyperendemic,
predominantly caused by P. falciparum. The entomologi-
cal inoculation rate (EIR), measured in an adjoining
urban area, is 50 infected bites per person per year [18]
and the main vectors are Anopheles gambiae and Anopheles
funestus. This study was conducted during both the high
rainy and dry seasons, from April 1995 to September
1996. Pregnant women (first and second pregnancy)
attending the SMI de la Peyrie (a maternal and child
health centre located in an urban area) were enrolled in
the study.
Ethical considerations
All work was performed according to the guidelines for
human experimentation in clinical research stated by the
Ministry of Public Health and Population of Gabon. All
women gave oral informed consent.
Data collection
Women in their first and second pregnancies were
included in the study when they came for their first
monthly antenatal visit. A number was attributed to each
one, which was recorded on a prenatal consultation form.
After a complete medical examination by nurse midwives
and two physicians, the volunteer's age, weight, length of
pregnancy, parity, exposure to antimalarial drug and axil-
lary temperature were noted. Women were considered as
having a fever when their temperature was ≥ 38°C. Gesta-
tional age was assessed using a gestational calendar, tri-
mester was defined as first (<14 weeks), second (14–27
weeks) and third (>27 weeks). The biological check-up
included measuring the haemoglobin rate (Hb), using
haemoglobin electrophoresis to detect sickle cell trait and
detecting parasitaemia.
Laboratory methods
Thick and thin blood films were stained with Giemsa and
read for malaria parasites by two trained microscopists
following standard, quality-controlled procedure [19].
Parasitaemia was expressed as the number of asexual
forms of P. falciparum per microlitre: a result was consid-
ered negative after a reading of 1,000 leucocytes in the
microscope (× 1,000). Haematological measurements
were verified using a Coulter Hycel HC plus HD 21, an
automated analyser. Parasitaemia was graded as low (1–
999/µl), moderate (1000–9999/µl) and high (>10000/
µl), haemoglobin levels as normal (>11 g/dl), low anae-
mia (11–9 g/dl), moderate anaemia (8.9–7 g/dl) and
severe anaemia (<7 g/dl), and age as teenagers (<20 years
old), young women (20–24 years old) and older women
(>24 years old). P. falciparum-positive women were
treated with quinine at 25 mg/kg/day during five days.
The alkaline pH electrophoresis of haemoglobin was per-
formed for sickle cell trait determination.
Statistical analysis
Data was analyzed using EpiInfo 6.04b and the Statview
software programme. For paired and unpaired compari-
sons of continuous variables, the non-parametric Wil-
coxon sign rank, the Kruskal-Wallis, and Mann-Withney
U-tests were used. Chi square analysis was used to com-
pare proportions within and among groups. Adjusted
tests were performed with the presence of malariaPage 2 of 7
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311 women were selected at their first ACC (antenatal
clinic care) at SMI de la Peyrie, patients' characteristics are
summarised in Table 1. 217 (70%) were primigravidae.
The mean age was 19 years (13–37) with 93% less than 25
years. Primigravidae were significantly younger than
secundigravidae (z = 3.20 p < 0.001). The mean length of
pregnancy was four months (1–6). 17 (5%) women had
started chemoprophylaxis with chloroquine (600 mg/
week). 248 (80%) had a normal haemoglobin (AA), 56
(18%) had haemoglobin AS and seven (2%) had haemo-
globin AC. There was no difference in distribution of these
variables between primigravidae and women in their sec-
ond pregnancy.
Malaria prevalence
Malaria prevalence was 57% (n = 177) (Table 1). All infec-
tions were diagnosed as P. falciparum. The median of par-
asitaemia in all infected women was 930 parasites/
microlitre (p/µl). Malaria prevalence was significantly
higher in primigravidae women (64%) than in women in
their second pregnancy (40%) (Odds ratio [OR] = 2.41,
95% confidence interval [CI] = 1.43 - 4.07, p < 0.001). Par-
asitaemic primigravidae women had higher median para-
sites density than parasitaemic secundigravidae (1050
versus 434 p/µL, z = 3.11, p = 0.002). (Table 1). The prev-
alence of parasitaemia did not vary with season (dry or
rainy). Overall, the parasite prevalence was 52% in the dry
season and 59% in the rainy season (OR = 1.3, 95% IC =
0.77 - 2.30, p = 0.48)(data not shown).
Relation with age
Although pregnant women were young, and only in their
first or second pregnancy, we compared the prevalence of
P. falciparum infection between teenagers, young and
older women. (Table 2). Parasitaemia was significantly
Table 1: Characteristics of the study groups
Number of women (n= 311) Primigravidae (n= 217) Secundigravidae (n= 94) Pa
Age mean years, (SD)b 19 (3.33) 19 (3.31) 21 (2.93) < 0.001
Age of pregnancy mean, 
months (SD)
4 (1.3) 4 (1.2) 4 (1.4)
Thick blood smear
Negative Noc, (%) 134 (43) 78 (36) 56 (60)
Positive No, (%) 177 (57) 139 (64) 38 (40) < 0.001
Lowd No, (%) 92 (52) 66 (47) 26 (68)
Moderate No, (%) 75 (42) 64 (46) 11 (29)
High No, (%) 10 (6) 9 (6) 1 (3)
Parasitaemiae
Median [IQR]f 930 [348–2808] 1050 [510–3060] 434 [149–2008] 0.002
Haemoglobin
Mean g/dl, (SD) 10.2 (1.4) 10.1 (1.4) 10.3 (1.3) NSg
Non anaemic No, (%) 90 (29) 61 (28) 29 (31)
Anaemic No, (%) 221 (71) 156 (72) 65 (69) NS
Lowh No, (%) 157 (71) 108 (69) 49 (75)
Moderate No, (%) 59 (27) 45 (29) 14 (22)
Severe No, (%) 5 (2) 3 (2) 2 (3)
EpHbi
AA No, (%) 248 (80)
AS No, (%) 56 (18)
AC No, (%) 7 (2)
Fever
yes No, (%) 84 (27)
no No, (%) 227 (73)
Chemoprophylaxis
yes No, (%) 17 (5)
no No, (%) 294 (95)
aP values for comparison between primigravidae and multigravidae. b Standard Deviation. c Number of pregnant women. d for definitions of parasi-
taemia see Patients and Methods. e parasitaemia in parasitaemic women. f interquartile range. g Not significant. h for definitions of anaemia see 
Patients and Methods. i Electrophoresis of Hb.Page 3 of 7
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and older women (55.5%) (χ2= 8.68, p = 0.013). No sig-
nificant difference was found between younger and older
women (OR = 1.09, 95% CI = 0.4 - 3.02, p = 0.85) (not
shown). We separately examined teenagers (< 20 years
old) and older (≥ 20 years old) women as well as primi-
gravidae and secundigravidae for influences on malaria.
Malaria prevalence was higher in teenagers than older
women (64% versus 47%, OR = 1.99, 95% CI = 1.22 -
3.25, p = 0.002). After correcting for parity, this difference
was also significant (OR = 1.77, 95% CI = 1.10 - 2.85, p <
0.01).
Relation with haemoglobin AS
Malaria prevalence was not influenced by the sickle cell
trait. Although 64% of Hb AS women were infected com-
pared to 55% Hb AA women, this difference was not sta-
tistically significant (OR = 1.4, 95% CI = 0.77 - 2.79), nor
were the medians of parasitaemia.
Relation with fever
In the groups recruited, 84 (27%) women had a fever.
Within this group, 39 women (46%) had a plasmodial
infection. The prevalence of plasmodial infection was sig-
nificantly higher in women without fever (61%) (OR =
0.55, 95% CI = 0.33 - 0.95, p = 0.023). There was no dif-
ference in the medians of parasitaemia between these
groups.
Relation with haemoglobin levels
Anaemia prevalence was 71% (n = 221) (Table 1). In
order to evaluate the effect of P. falciparum peripheral
infections in women with and without anaemia, we com-
pared the prevalence of parasitaemia. The presence of P.
falciparum asexual form in peripheral blood was highly
associated with anaemia. Indeed, anaemic women were
significantly more infected (63%) than non-anaemic
(41%) women (OR = 2.38, 95% CI = 1.4 - 4.05, p <
0.001). However, anaemia prevalence was similar
between primigravidae and secundigravidae (Table 1).
There was no significant difference between teenagers,
yound and older women (Table 1). Mean haemoglobin
level was 10.2 g/dl in all the enrolled women, and similar
between women of different gravidity (Table 1). Parasites
grade and anaemia classes are cross-tabulated in Table 1.
Moderately and severely anaemic women had higher par-
asite densities (medians 2818 and 1166 p/µl) than
women with low anaemia (981 p/µl). The lowest densi-
ties were observed in non-anaemic women. Association
between sickle cell trait carriage and haemoglobin levels
was assessed. The mean haemoglobin levels did not differ
between Hb AS women and Hb AA women (10 versus
10.2 g/dl, z = -1.12, p = 0.26), nor were the prevalence of
anaemia (71% versus 76.8%, OR = 1.08, 95% CI = 0.66 -
2.85, p = 0.37).
Relation with previous chloroquine chemoprophylaxis
Only 17 women (9 primigravidae and 8 secundigravidae)
had taken chemoprophylaxis from the beginning of preg-
nancy. When we compared the levels of parasitaemia in
this group to the other 294 women, we found that previ-
ous chloroquine prophylaxis had no effect on susceptibil-
ity to P. falciparum infection. The prevalence of infected
women was not different: 47% in group with chemo-
prophylaxis had malaria compared to 57% of the women
without previous chemoprophylaxis (OR = 1.19, 95% CI
= 0.4 - 3.46, p = 0.73). The medians of parasitaemia were
also similar (not shown).
Discussion
The susceptibility of pregnant women to malaria is well-
established [1,20]. However, no epidemiological data
have been recorded in Libreville, the capital city of Gabon,
where P. falciparum malaria is highly endemic. The aim of
this study was to evaluate the prevalence of malaria infec-
tion in Gabonese women who were pregnant and to
determine the relationship between this and gravidity
status, age, anaemia, the sickle cell trait and
chemoprophylaxis.
We found that malaria prevalence was 57%. As expected,
this prevalence was higher in primigravidae than secundi-
gravidae, and in women under 20 years old. Anaemia
prevalence was also higher, with a significant association
Table 2: Relation of age with parasitaemia and anaemia
Age years, (No)a ≤ 19 (180) 20 – 24 (109) > 24 (22) P
Non parasitaemic No, (%) 65 (36.1) 57 (52.3) 12 (54.5)
Parasitaemic No, (%) 115 (63.9) 52 (47.7) 10 (55.5) 0.01
Parasitaemia median [IQR]b 1200 [425–3260] 820 [224–1984] 784 [385–2668] NS c
Non anaemic No, (%) 47 (26.1) 35 (32.1) 8 (36.4)
Anaemic No, (%) 133 (73.9) 74 (67.9) 14 (67.6) NS
Hb mean g/dl, (SD)d 10 (1.3) 10.3 (1.4) 10.4 (1.5) NS
aNumber of pregnant women. b [IQR] = interquartile range. cNot significant. dStandard DeviationPage 4 of 7
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found that the presence of the sickle cell trait had no influ-
ence on malaria prevalence, nor did previous chemo-
prophylaxis. Likewise, age and gravidity had no effect on
anaemia. These results are in agreement with those
reported elsewhere, which show that P. falciparum infec-
tion is higher during pregnancy, more so in primigravidae
and is usually associated with anaemia or reduced haemo-
globin levels [21–27].
Our rationale for including pregnant women attending
the SMI de la Peyrie is that they are representative of the
general population in terms of accessibility to the health
centers, and they had low income. In Gabon, early preg-
nancies are frequent, and 60% of population is below 25
years of age, the age of most of the pregnant women
included in the study (93%). Women in their first and sec-
ond pregnancies were chosen as they constitute one of the
risk groups in stable malaria areas [20,28–31].
Previous studies conducted in different areas in Gabon,
have reported the prevalence of P. falciparum infection in
pregnant women in the same range of our results. These
studies were done at delivery [32,33]. Only the study con-
ducted by Garin et al. showed an increase of plasmodial
parasitaemia during pregnancy in primigravidae and
secundigravidae compared to multigravidae [34]. Our
findings are in general accordance with findings from
other areas (i.e. Malawi, Tanzania, Ghana, India), four
urban sites with similar malaria epidemiological charac-
teristics [21–24,31]. In these vulnerable populations,
primigravidae remain unquestionably the most suscepti-
ble: they are more often infected than multigravidae. In
the same epidemiological context, these levels of preva-
lence are similar to those reported by other authors: 65%
in Dielmo, Senegal [28], 62% in Tanzania [25], 65% in
Malawi [26] and 41% in Kenya [35]. The levels of parasi-
taemia are also high in primigravidae. This could be
explained by gravidity status, and as well as by the fact that
the women were, in most cases, recruited at the fourth
month of pregnancy. In the second trimester, parasitae-
mia is usually high compared to the first and the third tri-
mester [24,35]. Age and gravidity appeared to be the
principal influences of malaria prevalence, mostly in
teenagers.
Anaemia prevalence was also high in all women, i.e. 71%,
in agreement with the mean percentage for Africa (61%)
[36,37]. This prevalence is identical to that reported in a
group of pregnant women in Malawi [27] and Tanzania
[24]. A significant role in the determination of anaemia
has been demonstrated in this study. Women with low
anaemia had the highest prevalence of malaria (50%),
and higher parasite load was most common in women
with severe anaemia. Similar finding were reported from
Blantyre, Malawi [31]. In our study, gravidity and age did
not influence the prevalence of anaemia and the mean
heamoglobin levels. Therefore, all anaemia aetiologies in
pregnant women should be further investigated.
Fever has not been found to be a good indicator of clinical
malaria. Despite the fact that in endemic areas asympto-
matic P. falciparum infections are frequent in adults, our
study showed that malaria was not the main aetiology of
fever during pregnancy. Other causes like urinary and gen-
ital infection could be the cause and should be treated to
avoid subsequent obstetrical problems.
The prevalence of sickle cell trait in Gabon is about 22,5%
[38]. Furthermore, the prevalence of infection has been
reported to be lower in individuals with sickle cell trait
compared to the normal-haemoglobin counterparts [17].
In our study population, the prevalence of the sickle cell
trait was similar to the general population, and it did not
influence the prevalence of malarial infection. This is not
surprising: studies conducted by Van Dongen in Zambia
and Mockenhaupt in Ghana have also shown that they no
have no influence on each other [22,39].
Previous chloroquine chemoprophylaxis has no effect on
the prevalence of infection and parasitaemia. Chloro-
quine is still recommended as the first-line anti-malarial
drug in preventive treatment for pregnant women in
Gabon. It is widely used, affordable and available, thus, a
Table 3: Relationship between anaemia and parasitaemia
Parasitaemiaa 0 Low Moderate High Median [IQR]b
Haemoglobin, Noc (%)
<7 g/dl (n = 5) 1 (20) 1 (20) 2 (40) 1 (20) 2818 [1047–8376]
7 – 8.9 g/dl (n = 59) 16 (27.1) 21 (35.6) 19 (32.2) 3 (5.1) 1166 [527–3268]
9 – 11 g/dl (n = 157) 66 (41.4) 47 (29.9) 42 (26.8) 3 (1.9) 981 [321–2475]
>11 g/dl (n = 90) 53 (59) 21 (23.3) 12 (13.3) 4 (4.4) 728 [278–2242]
aFor definition of parasitaemia, see Patients and Methods. b [IQR] = interquartile range. Median for those parasitemic. cNumber of pregnant women 
in each parasitaemic group.Page 5 of 7
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Considering that the drug has been taken in correct doses,
and that pregnant women generally use insecticides, is
chloroquine still efficient in chemoprophylaxis since it is
known that its efficacy in curative treatment in children
and adults is less than 20% [40,41]?
Unfortunately, we did not evaluate some confounding
factors such as type of housing, stool hookworm burden
or human immunodeficiency virus serostatus that seem to
influence malaria and/or anaemia.
Conclusion
This study illustrates high prevalence of malaria and anae-
mia in pregnant women living in Libreville. Both are more
common in first pregnancies, and primiparity and young
age appear to be greater determinants of malaria risk.
Chloroquine is still recommended by national health pol-
icy in Gabon, and chloroquine resistance in curative doses
has been reported. Thus, an effective regimen of malaria
prophylaxis of women during their first and second preg-
nancies is strongly recommended.
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